Press release
Gastric Cancer Market Size Forecasted To Achieve 6.43 Billion By 2029 With Steady Growth
Gastric Cancer Market
What Is the Gastric Cancer Market Size and Projected Growth Rate?
The market size of gastric cancer has seen a swift expansion in the last few years. It is projected to expand from $3.17 billion in 2024 to $3.65 billion in 2025, maintaining a compound annual growth rate (CAGR) of 15.4%. Factors such as the increase in the elderly population, enhanced healthcare awareness, a surge in genetic mutations, the rise in unhealthy lifestyle practices, and increased cancer awareness, contributed to the growth during the historic period.
In the coming years, the market size for gastric cancer is predicted to witness a swift expansion. It is estimated to reach $6.43 billion by 2029 with a compound annual growth rate (CAGR) of 15.2%. Factors contributing to the growth during this forecasted period include a rise in obesity rates, escalating governmental initiatives, burgeoning investments in healthcare, an enhanced demand for oral drugs, and the increase in cancer treatment centers. The forecast period is also characterized by notable trends such as combined chemotherapy, product diversification, operations assisted by robots, focus on targeted therapies, strategic partnerships, and the utilization of more advanced diagnostic tools.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20797
What Are the Major Segments in the Gastric Cancer Market?
The gastric cancer market covered in this report is segmented -
1) By Type: Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Other Types
2) By Diagnosis: Endoscopy, Biopsy, Imaging Tests, Exploratory Surgery, Other Diagnosis
3) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Palliative Care, Other Treatments
4) By Distribution Channel: Hospital Pharmacies, Specialty And Retail Pharmacies, Other Distribution Channels
Subsegments:
1) By Adenocarcinoma: Intestinal Type Adenocarcinoma, Diffuse Type Adenocarcinoma, Mixed Type Adenocarcinoma
2) By Lymphoma: Primary Gastric Lymphoma, Secondary Gastric Lymphoma
3) By Gastrointestinal Stromal Tumor (GIST): Primary GIST, Metastatic GIST
4) By Carcinoid Tumor: Gastric Carcinoid Type 1, Gastric Carcinoid Type 2, Gastric Carcinoid Type 3
5) By Other Types: Small Cell Carcinoma, Squamous Cell Carcinoma, Mixed Tumors
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20797&type=smp
What Are The Driving Gastric Cancer Market Evolution?
The swelling numbers of obesity are anticipated to stimulate the expansion of the gastric cancer market. Defined by a body mass index (BMI) of 30 or above, obesity is a health condition characterized by an abnormal accumulation of body fat, which can result in numerous health complications. The increase in obesity rates can be attributed to elements such as unhealthy eating habits, insufficient physical exercise, inactive lifestyles, environmental variables, and genetic susceptibilities. Excessive body fat, especially intra-abdominal fat, is linked to an elevated risk of gastric cancer because it instigates chronic inflammation and metabolic disruptions, both of which are connected to cancer progression. This, in turn, fuels the need for gastric cancer treatment. As an example, the World Health Organization, an intergovernmental organization based in Switzerland, disclosed in March 2024 that roughly one in eight people worldwide in 2022 were obese, with 2.5 billion adults aged 18 and older categorized as overweight. This figure includes 890 million people affected by obesity. Among adults, 43% were overweight, and 16% were obese. Moreover, 37 million children below the age of five were overweight, and over 390 million children and adolescents between 5 and 19 years old were overweight, including 160 million living with obesity. Consequently, the escalating obesity rates are fueling the gastric cancer market.
Which Firms Dominate The Gastric Cancer Market Segments?
Major companies operating in the gastric cancer market are F. Hoffmann La Roche Ltd., Merck And Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb Company, Abbott Laboratories, Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen Biopharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Samsung Biologics Co. Ltd., Celltrion Healthcare Co. Ltd., Biocon Limited, Hanmi Pharmaceuticals, Mylan N.V., Taiho Oncology Inc., Hikma Pharmaceuticals PLC, Taiho Pharmaceuticals Co. Ltd., AROG Pharmaceuticals Inc.
What Trends Are Expected to Dominate the Acquired Autoimmune Hemolytic Anemia Market in the Next 5 Years?
Leaders in the gastric cancer market are concentrating on the development of technologically sophisticated solutions including companion diagnostic assays to facilitate individualized treatment plans. These assays are tests designed to pinpoint patients likely to respond positively to a specific therapeutic intervention, by detecting specific biomarkers. For instance, in October 2024, Swiss pharmaceutical corporation F. Hoffmann-La Roche Ltd., received US FDA approval for the VENTANA CLDN18 (43-14A) RxDx Assay. This assay happens to be the first immunohistochemistry (IHC) companion diagnostic serving to evaluate CLDN18 protein expression in gastric and gastroesophageal junction (GEJ) adenocarcinoma. This assay identifies patients suitable for targeted treatment with VYLOY (zolbetuximab) by recognizing CLDN18 protein variants, primarily CLDN18.2. These assays, used with the OptiView DAB IHC Detection Kit on the BenchMark ULTRA instrument, push forward personalized medicine and widen the range of treatment alternatives for gastric and GEJ adenocarcinoma.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/gastric-cancer-global-market-report
Which Is The Largest Region In The Gastric Cancer Market?
North America was the largest region in the gastric cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Gastric Cancer Market?
2. What is the CAGR expected in the Gastric Cancer Market?
3. What Are the Key Innovations Transforming the Gastric Cancer Industry?
4. Which Region Is Leading the Gastric Cancer Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastric Cancer Market Size Forecasted To Achieve 6.43 Billion By 2029 With Steady Growth here
News-ID: 4067457 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Gastric
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driving Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Gastric Ulcers Market Size By 2025?
In the last few years, the market size for gastric ulcers has been expanding notably. It is anticipated to increase from $4.29 billion in 2024 to $4.54 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.9%.…
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driver: Leadi …
How Are the key drivers contributing to the expansion of the gastric ulcers market?
The rising geriatric population is expected to accelerate the growth of the gastric ulcers market. The geriatric population, typically individuals aged 65 and above, is growing due to improvements in healthcare and increased life expectancy. This population is more susceptible to gastric ulcers due to factors like the use of NSAIDs and decreased mucosal protection. For instance,…
Top Factor Driving Gastric Cancer Drugs Market Growth in 2025: Rising Gastric Ca …
What market dynamics are playing a key role in accelerating the growth of the gastric cancer drugs market?
The rise in obesity and smoking rates has led to an increased prevalence of gastric cancer. Factors like tobacco use and poor dietary habits have been linked to a higher risk of developing this disease. As per data from the Government Digital Service in the UK, it was projected in May 2023 that…
Gastric Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Gastric Cancer Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the pipeline drug profiles, including Gastric Cancer clinical trials and nonclinical stage products. It also covers the Gastric Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Gastric Cancer…
Gastric Function Test Market - Empowering Digestive Health: Gastric Function Tes …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Gastric Function Test Market.
Gastric Function Test Market: https://www.growthplusreports.com/report/gastric-function-test-market/9126
The Gastric Function Test Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
The Virtual Gastric Band 101
There’s been a lot in the media recently about the Hypnotic Gastric Band or also known as The Virtual Gastric Band. I get asked a lot about it so thought I’d give a Virtual Gastric Band 101 on what it is, but more importantly what it’s not.
The Virtual Gastric Band - It is a non-surgical technique which uses the power of hypnosis to retrain the person to be satisfied with smaller…
